• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home The Classics Radiology Classics

CT scans increase the risk of malignancy in children and young adults [Classics Series]

byDeepti Shroff
August 15, 2022
in Radiology Classics, The Classics
Reading Time: 3 mins read
ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]
Share on FacebookShare on Twitter

This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials

1. In this retrospective cohort analysis of children and young adults without previous malignancy, patients exposed to multiple computed tomography (CT) scans had over 3 times the risk of developing leukemia and brain tumors.

Original Date of Publication: August 2012

Study Rundown: While the connection between radiation exposure and malignancy was previously identified, research on the subject matter drew from high-dose radiation exposure secondary to atomic bombs in Japan. At the time of its publication, this study was the first to use a cohort to examine the malignancy risk associated with low-dose radiation from CT scans. Through retrospective analysis, researchers investigated the relationship between CT-induced radiation exposure during childhood and young adulthood and development of leukemia and brain cancer, as these malignancies occur in particularly radiosensitive tissue. Children under the age of 15 who received 5-10 head CTs were exposed to around 50 milligrays (mGy) of radiation to their marrow, while 2-3 head CTs exposed these children to about 60 mGy of brain radiation. For comparison, the average chest radiograph exposes a child to 0.05 to 0.3 mGy.

Investigators reported an over 3 times increased risk of developing leukemia with exposure to ≥30 mGy and developing a brain tumor with ≥50 mGy of radiation. Limitations included using standardized CT machine settings as a proxy when assessing radiation exposure due to missing data regarding machine-specific settings. However, the use of a cohort from Great Britain’s national database ensured a large study group with low risk of loss to follow-up. This was the first cohort study to investigate the potential association between lower doses of radiation than the estimated 100 mGy of radiation exposure experienced by many Japanese atomic bomb victims. While the overall incidence of these malignancies is small within the pediatric population, this study does indicate significant risks associated with over-imaging developing children. With this in mind, the Alliance for Radiation Safety in Pediatric Imaging within the United States has started the “Image Gently” campaign, a movement designed to increase awareness of healthcare practitioners and caregivers to the benefits of reducing unnecessary radiation exposure.

Click to read the study in The Lancet

RELATED REPORTS

Real-time AI guidance enters live brain tumor surgery

Dipeptidyl peptidase-4 inhibitors may be associated with an increased incidence of malignancy

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

In-Depth [retrospective cohort]: A total of 355 191 patients seen at a Great Britain National Health Service hospital without a history of prior malignancy, but who underwent a first CT scan between 1985-2002 at ages younger than 22, were included in the study. The study group was divided such that 178 604 patients were investigated with respect to leukemia and 176 587 patients were studied with respect to brain tumors. Malignancies investigated included acute lymphoblastic leukemia, acute myeloid leukemia, myelodysplastic syndromes (MDS), leukemia excluding MDS, gliomas, meningiomas, and schwannomas. Relative risks were calculated to assess the relationship between the radiation doses expressed in mGy units and malignancy. Data were collected from a national registry and ended on December 31, 2008, at time of death, or when patients were lost to follow-up. During analysis, radiation doses were adjusted to reflect the time it typically takes to develop a malignancy. This resulted in a 2 year lag for leukemia and a 5 year lag for brain tumors.

Among the patients included in the leukemia analysis, 283 919 CT scans were completed (64% head) and 74 patients had developed leukemia on follow-up.  279 824 scans were completed for patients included in brain tumor analysis with 135 patients ultimately receiving diagnoses of brain tumors on follow-up. Significant positive associations between leukemia and CT radiation dosing (p <0.01) and brain tumors and radiation (p <0.001) were observed. Mean radiation dose was 51.13 mGy for patients who developed leukemia and with exposure to ≥30 mGy of radiation. Among those who received ≥30 mGy, patients were more than 3 times as likely to develop leukemia when compared to those who received <5 mGy (RR 3.18; 95%CI 1.46-6.94). Mean radiation dose for patients who received ≥50 mGy and developed brain tumors was 104.16 mGy. Those who received ≥50 mGy of radiation were at greater than 3 times the risk of developing a brain tumor when compared to those who were exposed to <5 mGy (RR 3.32; 95%CI 1.84-6.42).

Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumors: a retrospective cohort. The Lancet. 2012 Aug 4;380(9840):499–505.

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: brain tumorctleukemiamalignancy
Previous Post

Weighted blankets may reduce sleep medication use in psychiatric patients

Next Post

Criteria for low-dose computed tomography lung cancer screening omit a high risk population of smokers

RelatedReports

Imaging and Intervention

Real-time AI guidance enters live brain tumor surgery

September 11, 2026
Intrapartum serum prolactin may predict risk of postpartum diabetes
Chronic Disease

Dipeptidyl peptidase-4 inhibitors may be associated with an increased incidence of malignancy

March 26, 2026
Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation
Pharma

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

August 20, 2025
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Pharma

2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]

August 14, 2025
Next Post
Strict tobacco licensing laws linked to reduced adolescent smoking initiation

Criteria for low-dose computed tomography lung cancer screening omit a high risk population of smokers

Brain lesions on MRI linked with subsequent increased stroke risk

Cinpanemab therapy does not prevent Parkinson’s disease progression

Pediatric DKA associated with recent acute care visits

Dulaglutide improves glycemic control for youth with type 2 diabetes

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.